European Union (National Research Ethics Committees for Clinical Investigation of Medical Devices) (Amendment) Regulations 2026.

Download PDF Íoslódáil PDF Notice of the making of this Statutory Instrument was published in “Iris Oifigiúil” of rd February, 2026. I, JENNIFER CARROLL MACNEILL, Minister for Health, in exercise of the powers conferred on me by section 3 of the European Communities Act 1972 (No. 27 of 1972) and for the purpose of giving further effect to Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017, Regulation (EU) 2020/561 of the European Parliament and of the Council of 23 April 2020 and Regulation (EU) 607/2023 of the European Parliament and of the Council of 15 March 2023, hereby make the following regulations: 2. These Regulations shall come into operation on 1 February 2026. 4. The Principal Regulations are amended by deleting Regulation 35, and substituting it with the following: 35. (1) Subject to paragraph (2), the following fees shall be payable by a sponsor to the relevant National Office: (a) €1,650 in respect of each application for National REC review relating to the conduct of a clinical investigation in the State, (b) €440 in respect of each application for National REC review of a substantial modification of a clinical investigation, and (c) €2000 in respect of each appeal under Regulation 24 (which fee shall be refundable if the appeal is successful). (2) Paragraph (1) does not apply to applications relating to a non-commercial clinical investigations. (3) The National Office may recover, as a simple contract debt in any court of competent jurisdiction, from the person by whom it is payable, any amount due and owing to it as a fee payable under this Regulation.’ GIVEN under my Official Seal, 29 January, 2026. JENNIFER CARROLL MACNEILL, Minister for Health. EXPLANATORY NOTE This note is not part of the Instrument and does not purport to be a legal interpretation.